[1]
E. Atayık and G. Aytekin, “Safety of allergen immunotherapy in patients with SARS-CoV-2 infection”, Eur Res J, vol. 8, no. 5, pp. 642–649, Sep. 2022, doi: 10.18621/eurj.1086549.